We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CRGX CARGO Therapeutics Inc

1.34 (8.96%)
Dec 01 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 273,478
Bid Price 16.29
Ask Price 18.35
News -
Day High 16.48


52 Week Range


Day Low 14.49
Company Name Stock Ticker Symbol Market Type
CARGO Therapeutics Inc CRGX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.34 8.96% 16.29 17:14:16
Open Price Low Price High Price Close Price Prev Close
15.17 14.49 16.48 16.29 14.95
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,338 273,478 $ 15.27 $ 4,175,459 - 13.14 - 16.48
Last Trade Time Type Quantity Stock Price Currency
19:27:35 1 $ 16.30 USD

CARGO Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 629.98M - - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

CARGO Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No CRGX Message Board. Create One! See More Posts on CRGX Message Board See More Message Board Posts

Historical CRGX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week14.7216.4814.0015.1451,6121.5710.67%
1 Month15.4516.4813.1414.70251,2410.845.44%
3 Months15.4516.4813.1414.70251,2410.845.44%
6 Months15.4516.4813.1414.70251,2410.845.44%
1 Year15.4516.4813.1414.70251,2410.845.44%
3 Years15.4516.4813.1414.70251,2410.845.44%
5 Years15.4516.4813.1414.70251,2410.845.44%

CARGO Therapeutics Description

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |